☆ 4.6 Article

A Randomized Phase II Study of Gemcitabine and Carboplatin with or without Cediranib as First-Line Therapy in Advanced Non-Small-Cell Lung Cancer North Central Cancer Treatment Group Study N0528

JOURNAL OF THORACIC ONCOLOGY (2013)

Rate this paper

The primary rating indicates the level of overall quality for the paper. Secondary ratings independently reflect strengths or weaknesses of the paper.

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

A Randomized Phase II Study of Gemcitabine and Carboplatin with or without Cediranib as First-Line Therapy in Advanced Non-Small-Cell Lung Cancer North Central Cancer Treatment Group Study N0528

Rate this paper

Find the ideal target journal for your manuscript

Ask a Question. Answer a Question.

Export Citation

Share Paper